#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
medScope.pro

Medical News

makak

A Cloned Monkey Survived to Adulthood for the First Time. Will We Soon Be Able to Clone Humans?

4. 3. 2024 Source: medScope.pro

A macaque named ReTro, born as a result of a cloning experiment by Chinese scientists, has reached adulthood. This is the first such successful cloning that could pave the way for further primate research. What is behind the scientists' success? And does this mean we could successfully clone humans?

zlomenina kost

Can we properly manage osteoporotic fractures?

Osteoporotic fractures are associated with increased morbidity and mortality and often lead to an overall deterioration in the quality of life. We should not forget to diagnose osteoporosis in…
29. 2. 2024 Source: Osteoporosis – Trends in Sequential Therapy
kost

Meta-analysis of the Effectiveness of Romosozumab in the Treatment of Postmenopausal Osteoporosis

Osteoporosis is a prevalent disease with unmet therapeutic needs. Whether the anti-sclerostin antibody romosozumab can offer an effective improvement in osteoporosis treatment outcomes in…
29. 2. 2024 Source: Osteoporosis – Trends in Sequential Therapy
paranoidní schizofrenie_muž

Lurasidone in a Patient with Paranoid Schizophrenia and Asperger's Syndrome –⁠ A Case Study

Lurasidone is an effective and very gentle antipsychotic which is establishing a prominent position in modern psychopharmacotherapy. Its unique receptor profile makes it a suitable choice for…
27. 2. 2024 Source: Modern Treatment of Schizophrenia
hypotyreózy

Clinical Significance of Smaller Gaps Between Strengths of Levothyroxine Preparations in the Treatment of Hypothyroidism

Many levothyroxine preparations have relatively large intervals between doses (25 µg, 50 µg, and 75 µg), creating obstacles for some patients to achieve an optimal maintenance dose. The availability…
23. 2. 2024 Source: Thyroid Disorders
stitna zlaza

Generic Substitution of Levothyroxine in Practice

The active ingredient levothyroxine is found in a significant number of medicinal products (MP) in the Czech Republic. The question of its generic substitution remains current, primarily because the…
22. 2. 2024 Source: Thyroid Disorders
Malobuněčný karcinom plic

Options for Systemic Therapy of Advanced Stage Small Cell Lung Cancer

Small cell lung cancer (SCLC) is the most aggressive type of lung tumor. Although it responds well to chemotherapy and radiotherapy, due to the early onset of treatment resistance, the 5-year…
22. 2. 2024 Source: Small Cell Lung Cancer
Karcinom prsu

Current Sequence of Treatment for Metastatic HER2+ Breast Cancer

In September 2023, experts from Miami Cancer Institute published their consensus statement on the treatment of HER2-positive advanced breast cancer (BC). The latest change in therapeutic strategy is…
22. 2. 2024 Source: Ovarian and Breast Cancer
Oko AI

Artificial Intelligence and Deep Learning as the Future of Glaucoma Diagnosis

Glaucoma represents a group of eye diseases characterized by changes to the optic nerve. It is the second most common cause of blindness, currently affecting more than 90 million people worldwide. It…
21. 2. 2024 Source: medScope.pro
MUDr. Zárubová FOTO

MUDr. Jana Zárubová: Experiences with buccal midazolam in real practice are positive and we can significantly improve patients' quality of life

Recently, it has emerged as an alternative to traditionally rectally administered diazepam for stopping prolonged convulsive seizures in patients with epilepsy. What can buccal midazolam offer them…
21. 2. 2024 Source: Quick aid for acute convulsive seizures in children and adolescents
Epilepsie_žena

IEC 2023: Key Challenges for Epilepsy Patients Include Status Epilepticus and Anxiety Management

Why is anxiety a significant issue for epilepsy patients? What do current insights say about the connection between epilepsy and anxiety? Can artificial intelligence be used to predict status…
21. 2. 2024 Source: Quick aid for acute convulsive seizures in children and adolescents
MOZOG NEURON

Ocrelizumab in the Treatment of Multiple Sclerosis –⁠ 10-Year Data

Multiple sclerosis (MS) is a lifelong disease with a high risk of permanent disability. Current information on the long-term efficacy and safety of treatment is therefore absolutely essential for the…
20. 2. 2024 Source: Neurology - Multiple Sclerosis
symptomatická léčba

Long-term Efficacy and Safety of Mavacamten in the Treatment of Obstructive HCM

Interim results of the MAVA-LTE study provide the latest data on the long-term safety and efficacy of symptomatic treatment with mavacamten for obstructive hypertrophic cardiomyopathy (oHCM), with…
19. 2. 2024 Source: Hypertrophic Cardiomyopathy (HCM)
farmakoterapie

Mavacamten in the Treatment of HCM in Patients Referred for Septal Reduction

Extended 56-week follow-up of patients with hypertrophic cardiomyopathy (HCM) resistant to current pharmacotherapy in the VALOR-HCM study confirmed the lasting benefit of mavacamten –⁠ the first…
19. 2. 2024 Source: Hypertrophic Cardiomyopathy (HCM)
starší muž aktivita

How Does Myelodysplastic Syndrome Affect Patients' Quality of Life?

Myelodysplastic syndrome (MDS) is a heterogeneous group of disorders of hematopoietic stem cells with varying degrees of risk of progression to acute myeloid leukemia (AML). The therapeutic options…
15. 2. 2024 Source: Myelodysplastic Syndrome (MDS)
1 … 14 15 16 17 18 … 111
Filter by speciality
Remove filters
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#